Frontlight ResearchEarly access
Trial site
Shunde Hospital of Southern Medical University
- 7running trials
- 4closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- COPD2 trials
- Asthma1 trial
- Chronic kidney disease1 trial
- High blood pressure1 trial
- Liver and biliary tract cancer1 trial
- Liver cirrhosis1 trial
- Lung cancer1 trial
- Multiple myeloma1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 24 trials
- Phase 12 trials
- Phase 32 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Active, not recruiting4 trials
- Completed4 trials
- Not yet recruiting2 trials
- Recruiting1 trial
- Lead sponsor
- Beijing Protgen Biotechnology Development Co., Ltd.1 trial
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1 trial
- Excyte Biopharma Ltd1 trial
- Nanjing Minova Pharmaceutical Co., Ltd.1 trial
- RemeGen Co., Ltd.1 trial
- and 6 more
Running trials
Active, not recruiting
Active, not recruiting
A Phase Ib Study of RC148 as Monotherapy or Combination for Locally Advanced or Metastatic NSCLC
Active, not recruiting
Active, not recruiting
Recruiting
A Study of YKST02 in Participants With Relapsed or Refractory Multiple Myeloma
Not yet recruiting
Not yet recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Liver and biliary tract cancer1 recruiting
- Multiple myeloma1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026